Management for persistent HPV infection and cervical lesions among women infected with HIV: a retrospective observational cohort study.
Humans
Female
HIV Infections
/ complications
Papillomavirus Infections
/ complications
Retrospective Studies
Adult
Middle Aged
Uterine Cervical Dysplasia
/ virology
Uterine Cervical Neoplasms
/ virology
Coinfection
/ virology
China
/ epidemiology
Genotype
Prevalence
Papillomaviridae
/ genetics
Persistent Infection
/ virology
Young Adult
Cervical lesion
Clinical management
Co-infection
HIV
HPV
Journal
Virology journal
ISSN: 1743-422X
Titre abrégé: Virol J
Pays: England
ID NLM: 101231645
Informations de publication
Date de publication:
06 Jun 2024
06 Jun 2024
Historique:
received:
17
04
2024
accepted:
03
06
2024
medline:
7
6
2024
pubmed:
7
6
2024
entrez:
6
6
2024
Statut:
epublish
Résumé
Early diagnosis and treatment of HPV persistent infection and cervical intraepithelial neoplasia, which have yet to be thoroughly characterized in Guangxi, Southwestern China, are the key preventative measures for the development of cervical cancer in women, particularly in HIV-infected women. A retrospective study of 181 patients with HPV infection or cervical intraepithelial neoplasia who received surgical excision of lesions and were prospectively enrolled at the Fourth People's Hospital of Nanning between January 2018 and February 2023 was performed. HPV-infected patients were divided into two subgroups: HIV-infected and HIV/HPV-coinfected patients and compare differences between these groups. HPV16, 18, 52, and 58 were the most prevalent HPV genotypes. High-risk HPV was significantly co-infected with multiple genotypes (P = 0.0332). HIV-infected women were predisposed to HPV infection (P < 0.0001), and the development of cervical cancer at a young age (P = 0.0336) compared to HIV-uninfected women and the loop electrosurgical excision procedure (P = 0.0480) is preferred for the treatment. HIV infection may increase HPV prevalence and lead to cervical cancer development at a young age. The loop electrosurgical excision procedure is an efficient evaluation and treatment strategy for HIV-infected women suffering from cervical intraepithelial neoplasia.
Sections du résumé
BACKGROUND
BACKGROUND
Early diagnosis and treatment of HPV persistent infection and cervical intraepithelial neoplasia, which have yet to be thoroughly characterized in Guangxi, Southwestern China, are the key preventative measures for the development of cervical cancer in women, particularly in HIV-infected women.
METHODS
METHODS
A retrospective study of 181 patients with HPV infection or cervical intraepithelial neoplasia who received surgical excision of lesions and were prospectively enrolled at the Fourth People's Hospital of Nanning between January 2018 and February 2023 was performed. HPV-infected patients were divided into two subgroups: HIV-infected and HIV/HPV-coinfected patients and compare differences between these groups.
RESULTS
RESULTS
HPV16, 18, 52, and 58 were the most prevalent HPV genotypes. High-risk HPV was significantly co-infected with multiple genotypes (P = 0.0332). HIV-infected women were predisposed to HPV infection (P < 0.0001), and the development of cervical cancer at a young age (P = 0.0336) compared to HIV-uninfected women and the loop electrosurgical excision procedure (P = 0.0480) is preferred for the treatment.
CONCLUSIONS
CONCLUSIONS
HIV infection may increase HPV prevalence and lead to cervical cancer development at a young age. The loop electrosurgical excision procedure is an efficient evaluation and treatment strategy for HIV-infected women suffering from cervical intraepithelial neoplasia.
Identifiants
pubmed: 38844960
doi: 10.1186/s12985-024-02405-y
pii: 10.1186/s12985-024-02405-y
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
133Informations de copyright
© 2024. The Author(s).
Références
Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R et al. Cancer incidence in five continents volume IX. Int Agency Res Cancer. 2021. https://doi.org/https://ci5.iarc.who.int/ .
Sung HFJS. Global cancer statistics 2020: global cancer estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca: A Cancer Journal for Clinicians. 2021; 71:209 – 49. https://doi.org/10.3322/caac.21660 .
Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Sci (American Association Advancement Science). 1990;248(4951):76–9. https://doi.org/10.1126/science.2157286 .
doi: 10.1126/science.2157286
Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of ~ 53. Cell. 1990;63:1129–36. https://doi.org/10.1016/0092-8674(90)90409-8 .
doi: 10.1016/0092-8674(90)90409-8
pubmed: 2175676
Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of ~ 53. Cell. 1993;75:495–505. https://doi.org/10.1016/0092-8674(93)90384-3 .
doi: 10.1016/0092-8674(93)90384-3
pubmed: 8221889
Waggoner SE. Cervical cancer. Lancet. 2003;361:2217–25. https://doi.org/10.1016/S0140-6736(03)13778-6 .
doi: 10.1016/S0140-6736(03)13778-6
pubmed: 12842378
Münger K, Werness BA, Dyson N, Phelps WC, Harlow E, Howley PM. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 1989;8(13):4099–105. https://doi.org/10.1002/j.1460-2075.1989.tb08594.x .
doi: 10.1002/j.1460-2075.1989.tb08594.x
pubmed: 2556261
pmcid: 401588
Chellappan S, Kraus VB, Kroger B, Munger K, Howley PM, Phelps WC et al. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between the transcription factor E2F and the retinoblastoma gene product. Proceedings of the National Academy of Sciences. 1992; 89:4549-53. https://doi.org/10.1073/pnas.89.10.4549 .
Yang X, Li Y, Tang Y, Li Z, Wang S, Luo X, et al. Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021. Emerg Microbes Infect. 2023;12(1):e2176009. https://doi.org/10.1080/22221751.2023.2176009 .
doi: 10.1080/22221751.2023.2176009
pubmed: 36744409
pmcid: 9936994
Soto D, Song C, Mclaughlin-Drubin ME. Epigenetic alterations in human papillomavirus-associated cancers. Viruses. 2017;9(9). https://doi.org/10.3390/v9090248 .
Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, Ghissassi FE, et al. A review of human carcinogens—part B: biological agents. Lancet Oncol. 2009;10(4):321–2. https://doi.org/10.1016/S1470-2045(09)70096-8 .
doi: 10.1016/S1470-2045(09)70096-8
pubmed: 19350698
Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, Broker TR, et al. The biology and life-cycle of human papillomaviruses. Vaccine. 2012;30. https://doi.org/10.1016/j.vaccine.2012.06.083 . F55-70.
Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518–27. https://doi.org/10.1056/NEJMoa021641 .
doi: 10.1056/NEJMoa021641
pubmed: 12571259
Paul A, Cohen AJAO. Cervical cancer. Lancet. 2019;393:169–82. https://doi.org/10.1016/S0140-6736(18)32470-X .
doi: 10.1016/S0140-6736(18)32470-X
Clark E, Chen L, Dong Y, Raychaudhury S, White D, Kramer JR, et al. Veteran women living with human immunodeficiency virus have increased risk of human papillomavirus (HPV)-associated genital tract cancers. Clin Infect Dis. 2021;72(9):e359–66. https://doi.org/10.1093/cid/ciaa1162 .
doi: 10.1093/cid/ciaa1162
pubmed: 32785700
Cox JT. Management of cervical intraepithelial neoplasia. Lancet. 1999;353:857–9. https://doi.org/10.1016/S0140-6736(98)00392-4 .
doi: 10.1016/S0140-6736(98)00392-4
pubmed: 10093973
Basu P, Taghavi K, Hu S, Mogri S, Joshi S. Management of cervical premalignant lesions. Curr Probl Cancer. 2018;42(2):129–. https://doi.org/10.1016/j.currproblcancer.2018.01.010 . https://doi.org/https://doi.org/ . 36.
doi: 10.1016/j.currproblcancer.2018.01.010
pubmed: 29428790
Prendiville W, Davies R, Berry PJ. A low voltage diathermy loop for taking cervical biopsies: a qualitative comparison with punch biopsy forceps. Br J Obstet Gynaecol. 1986;93(7):773–6. https://doi.org/10.1111/j.1471-0528.1986.tb08066.x .
doi: 10.1111/j.1471-0528.1986.tb08066.x
pubmed: 3730349
Olorunfemi G, Ndlovu N, Masukume G, Chikandiwa A, Pisa PT, Singh E. Temporal trends in the epidemiology of cervical cancer in South Africa (1994–2012). Int J Cancer. 2018;143(9):2238–49. https://doi.org/10.1002/ijc.31610 .
doi: 10.1002/ijc.31610
pubmed: 29786136
pmcid: 6195436
Rahel Ghebre SGMJ. Cervical cancer control in HIV-infected women: past, present and future. Gynecol Oncol Rep. 2017;21:101–8. https://doi.org/10.1016/j.gore.2017.07.009 .
doi: 10.1016/j.gore.2017.07.009
pubmed: 28819634
pmcid: 5548335
Han MR, Shin S, Park HC, Kim MS, Lee SH, Jung SH, et al. Mutational signatures and chromosome alteration profiles of squamous cell carcinomas of the vulva. Exp Mol Med. 2018;50(2):e442. https://doi.org/10.1038/emm.2017.265 .
doi: 10.1038/emm.2017.265
pubmed: 29422544
pmcid: 5903820
Mitchell Maiman RGFE. Human lmmunodeficiency virus infection and cervical neoplasia. Gynecol Oncol. 1990;38(3):377–82. https://doi.org/10.1016/0090-8258(90)90077-X .
doi: 10.1016/0090-8258(90)90077-X
Martínez-Gómez X, Curran A, Campins M, Alemany L, Rodrigo-Pendás JÁ, Borruel N, et al. Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016. Euro Surveillance: Bulletin Européen. Sur Les Maladies Transmissibles. 2019;24(7). https://doi.org/10.2807/1560-7917.ES.2019.24.7.1700857 .
Crowley-Nowick PA, Ellenberg JH, Vermund SH, Douglas SD, Holland CA, Moscicki AB. Cytokine profile in genital tract secretions from female adolescents: impact of human immunodeficiency virus, human papillomavirus, and other sexually transmitted pathogens. J Infect Dis. 2000;181(3):939–45. https://doi.org/10.1086/315311 .
doi: 10.1086/315311
pubmed: 10720516
Castle PE. Cervical cancer prevention and control in women living with human immunodeficiency virus. Cancer J Clin. 2021;71(6):505–26. https://doi.org/10.3322/caac.21696 .
doi: 10.3322/caac.21696
Firnhaber C, Van Le H, Pettifor A, Schulze D, Michelow P, Sanne IM, et al. Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa. Cancer Causes Control. 2010;21(3):433–43. https://doi.org/10.1007/s10552-009-9475-z .
doi: 10.1007/s10552-009-9475-z
pubmed: 19949850
Wu Z, Chen, Junfang, Scott S, Robbins, McGoogan, Jennifer M. History of the HIV epidemic in China. Curr HIV/AIDS Rep. 2019;16:458–66. https://doi.org/10.1007/s11904-019-00471-4 .
doi: 10.1007/s11904-019-00471-4
pubmed: 31773405
pmcid: 7088640
Moscicki AB, Ellenberg JH, Farhat S, Xu J. Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type. J Infect Dis. 2004;190(1):37–45. https://doi.org/10.1086/421467 .
doi: 10.1086/421467
pubmed: 15195241
Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA. Risk of human papillomavirus–associated cancers among persons with AIDS. JNCI: Journal of the National Cancer Institute. 2009;101(16):1120-30. https://doi.org/10.1093/jnci/djp205 .
Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, Mcneel TS, Scoppa SM, et al. Trends in cancer risk among people with AIDS in the United States 1980–2002. AIDS. 2006;20(12):1645–54. https://doi.org/10.1097/01.aids.0000238411.75324.59 .
doi: 10.1097/01.aids.0000238411.75324.59
pubmed: 16868446
Darwich L, Cañadas M, Videla S, Coll J, Molina-López RA, Sirera G, et al. Prevalence, clearance, and incidence of human papillomavirus type–specific infection at the anal and penile site of HIV-infected men. Sex Transm Dis. 2013;40(8):611–8. https://doi.org/10.1097/01.OLQ.0000430798.61475.08 .
doi: 10.1097/01.OLQ.0000430798.61475.08
pubmed: 23859907
de Pokomandy A, Rouleau D, Ghattas G, Vezina S, Cote P, Macleod J, et al. Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study. J Infect Dis. 2009;199(7):965–73. https://doi.org/10.1086/597207 .
doi: 10.1086/597207
pubmed: 19239366
Abraham AG, D’Souza G, Jing Y, Gange SJ, Sterling TR, Silverberg MJ, et al. Invasive cervical cancer risk among HIV-infected women: a north American multicohort collaboration prospective study. J Acquir Immune Defic Syndr. 2013;62(4):405–13. https://doi.org/10.1097/QAI.0b013e31828177d7 .
doi: 10.1097/QAI.0b013e31828177d7
pubmed: 23254153
pmcid: 3633634
Adebamowo SN, Olawande O, Famooto A, Dareng EO, Offiong R, Adebamowo CA. Persistent low-risk and high-risk human papillomavirus infections of the uterine cervix in HIV-negative and HIV-positive women. Front Public Health. 2017;5:178. https://doi.org/10.3389/fpubh.2017.00178 .
doi: 10.3389/fpubh.2017.00178
pubmed: 28785554
pmcid: 5519520
Dyson N. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 1989;4893(243):934–7. https://doi.org/10.1126/science.2537532 .
doi: 10.1126/science.2537532
Geskus RB, González C, Torres M, Del Romero J, Viciana P, Masiá M, et al. Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men. AIDS. 2016;30(1):37–44. https://doi.org/10.1097/QAD.0000000000000874 .
doi: 10.1097/QAD.0000000000000874
pubmed: 26355673
Martin-Hirsch PP, Paraskevaidis E, Bryant A, Dickinson HO. Surgery for cervical intraepithelial neoplasia (review). Cochrane Database Syst Rev. 2013;12CD001318. https://doi.org/10.1002/14651858.CD001318 .
Pierre PL, Martin-Hirsch E, Paraskevaidis A, Bryant, Heather O, Dickinson, Sarah L, Keep. Surgery for cervical intraepithelial neoplasia (review). Cochrane Database Syst Rev. 2010;6CD001318. https://doi.org/10.1002/14651858.CD001318 .
Santesso N, Mustafa RA, Wiercioch W, Kehar R, Gandhi S, Chen Y, et al. Systematic reviews and meta-analyses of benefits and harms of cryotherapy, leep, and cold knife conization to treat cervical intraepithelial neoplasia. Int J Gynaecol Obstet. 2016;132(3):266–71. https://doi.org/10.1016/j.ijgo.2015.07.026 .
doi: 10.1016/j.ijgo.2015.07.026
pubmed: 26643302
Follen Mitchell M, Tortolero-Luna G, Cook E, Whittaker L, Rhodes-Morris H, Silva E. A randomized clinical trial of cryotherapy, laser vaporization, and loop electrosurgical excision for treatment of squamous intraepithelial lesions of the cervix. Obstet Gynecol. 1998;92(5):737–44. https://doi.org/10.1016/S0029-7844(98)00246-4 .
doi: 10.1016/S0029-7844(98)00246-4
Ferenczy A, Choukroun D, Arseneau J. Loop electrosurgical excision procedure for squamous intraepithelial lesions of the cervix: advantages and potential pitfalls. Obstet Gynecol. 1996;87(3):332–7. https://doi.org/10.1016/0029-7844(95)00453-X .
doi: 10.1016/0029-7844(95)00453-X
pubmed: 8598950
Katemba C, Muzoora C, Muwanguzi E, Mwambi B, Atuhairwe C, Taremwa IM. Hematological abnormalities in HIV-antiretroviral therapy naïve clients as seen at an immune suppression syndrome clinic at Mbarara regional referral hospital, Southwestern Uganda. J Blood Med. 2018;9:105–10. https://doi.org/10.2147/JBM.S157148 .
doi: 10.2147/JBM.S157148
pubmed: 29983600
pmcid: 6027711
Antoniak S. The coagulation system in host defense. Res Pract Thromb Haemost. 2018;2(3):549–57. https://doi.org/10.1002/rth2.12109 .
doi: 10.1002/rth2.12109
pubmed: 30046760
pmcid: 6046589